Published in Eur J Immunogenet on July 20, 1999
Comparative genomics of major histocompatibility complexes. Immunogenetics (2004) 2.31
NKG2D ligands as therapeutic targets. Cancer Immun (2013) 1.26
Genomic evolution of MHC class I region in primates. Proc Natl Acad Sci U S A (2005) 1.08
The implications of intergenic polymorphism for major histocompatibility complex evolution. Genetics (2000) 0.95
Possible polyphyletic origin of major histocompatibility complex class I chain-related gene A (MICA) alleles. J Mol Evol (2003) 0.75
Nomenclature for the major histocompatibility complexes of different species: a proposal. Immunogenetics (1990) 3.53
Statement on the nomenclature of human C4 allotypes. Immunobiology (1983) 2.66
Cell-mediated cytotoxicity to muscle in polymyositis. Effect of immunosuppression. N Engl J Med (1973) 2.25
An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens (2004) 2.20
Disease associations with complotypes, supratypes and haplotypes. Immunol Rev (1983) 1.87
Central MHC genes, IgA deficiency and autoimmune disease. Immunol Today (1990) 1.81
The P5 multicopy gene family in the MHC is related in sequence to human endogenous retroviruses HERV-L and HERV-16. Immunogenetics (1999) 1.71
Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease. Immunol Rev (1999) 1.65
Experimental myositis associated with hypersensitivity to muscle. J Pathol Bacteriol (1965) 1.59
Ancestral haplotypes: conserved population MHC haplotypes. Hum Immunol (1992) 1.48
Super high resolution for single molecule-sequence-based typing of classical HLA loci at the 8-digit level using next generation sequencers. Tissue Antigens (2012) 1.44
Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol (1993) 1.39
Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia. Clin Exp Immunol (1975) 1.38
Laboratory tests in clinical immunology: a critique. Am J Med (1980) 1.34
Autoimmunity in ocular and generalised myasthenia gravis. J Neuroimmunol (1981) 1.32
An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics (1992) 1.32
Antibodies to skeletal muscle demonstrated by immunofluorescence in experimental autoallergic myositis. Clin Exp Immunol (1971) 1.28
Complement allotyping in SLE: association with C4A null. Aust N Z J Med (1983) 1.24
SNP profile within the human major histocompatibility complex reveals an extreme and interrupted level of nucleotide diversity. Genome Res (2000) 1.24
Rearrangement of 21-hydroxylase genes in disease-associated MHC supratypes. Immunogenetics (1986) 1.23
Genetic control of suppressor lymphocyte function in myasthenia gravis: relationship of impaired suppressor function to HLA-B8/DRW3 and cold reactive lymphocytotoxic antibodies. Clin Immunol Immunopathol (1979) 1.23
Observer variation in grading sacroiliac radiographs in HLA-B27 positive individuals. J Rheumatol (1983) 1.23
Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS (1992) 1.20
HLA and complement allotypes in Type 1 (insulin-dependent) diabetes. Diabetologia (1983) 1.20
Human natural killer (NK) alloreactivity and its association with the major histocompatibility complex: ancestral haplotypes encode particular NK-defined haplotypes. J Exp Med (1993) 1.18
Immune function in ankylosing spondylitis: apparent relationship between streptococcal responses and HLA B27. J Rheumatol Suppl (1977) 1.17
Extensive nucleotide variability within a 370 kb sequence from the central region of the major histocompatibility complex. Gene (1999) 1.12
Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM. Immunogenetics (1992) 1.11
An analysis of variation in the long-range genomic organization of the human major histocompatibility complex class II region by pulsed-field gel electrophoresis. Genomics (1989) 1.11
Cancer in connective tissue disease. Arthritis Rheum (1982) 1.11
Exposure to blood borne infections in health care workers. Med J Aust (1992) 1.10
Use of the B27 test in the diagnosis of ankylosing spondylitis: a statistical evaluation. Arthritis Rheum (1981) 1.08
A new polymorphic and multicopy MHC gene family related to nonmammalian class I. Immunogenetics (1994) 1.07
Family studies of IgA deficiency. Immunogenetics (1985) 1.07
Hepatocellular carcinoma: presentation with vertebral metastases and radicular compression. Cancer (1972) 1.07
Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection. Tissue Antigens (2007) 1.05
The diagnostic significance of autoantibodies to the acetylcholine receptor. J Neuroimmunol (1982) 1.05
Diagnostic significance of thyroid microsomal antibodies in randomly selected population. Lancet (1980) 1.05
Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods (1988) 1.04
HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis. Br Med J (Clin Res Ed) (1983) 1.04
Four-digit allele genotyping of the HLA-A and HLA-B genes in Japanese patients with Behcet's disease by a PCR-SSOP-Luminex method. Tissue Antigens (2006) 1.03
Perinatal concentrations of progesterone, lactose and alpha-lactalbumin in the mammary secretion of women. J Endocrinol (1977) 1.03
Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma. Oncogene (2012) 1.03
Extensive deletions and insertions in different MHC supratypes detected by pusled field gel electrophoresis. J Exp Med (1988) 0.99
Major histocompatibility complex genes influence the outcome of HIV infection. Ancestral haplotypes with C4 null alleles explain diverse HLA associations. Hum Immunol (1990) 0.99
Autoantibodies and HLA antigens in ocular, generalized and penicillamine-induced myasthenia gravis. Ann N Y Acad Sci (1981) 0.99
Different evolutionary histories in two subgenomic regions of the major histocompatibility complex. Genome Res (1999) 0.99
Cross-reactivity of anti-acetylcholine receptor autoantibodies. Muscle Nerve (1981) 0.98
Immune function in ankylosing spondylitics and their relatives: influence of disease and HLA B27. Clin Exp Immunol (1978) 0.98
Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies. Am J Med (1977) 0.98
Novel cynomolgus macaque MHC-DPB1 polymorphisms in three South-East Asian populations. Tissue Antigens (2006) 0.98
Neural network in planarian revealed by an antibody against planarian synaptotagmin homologue. Biochem Biophys Res Commun (1999) 0.97
HLA class I and II alleles and haplotypes in ethnic Northeast Thais. Tissue Antigens (2010) 0.97
Characterisation of immunofluorescent heterophile antibodies which may be confused with autoantibodies. J Clin Pathol (1977) 0.97
Differences in gene copy number carried by different MHC ancestral haplotypes. Quantitation after physical separation of haplotypes by pulsed field gel electrophoresis. J Exp Med (1990) 0.96
Reference ranges for serum C4 concentrations in subjects with and without C4 null alleles. J Clin Pathol (1986) 0.96
Changes in the composition of the mammary secretion of women after abrupt termination of breast feeding. J Physiol (1978) 0.96
Detection of cytomegalovirus in blood donors by the polymerase chain reaction. Transfusion (1993) 0.96
Positive allergy prick tests associated with bronchial histamine responsiveness in an unselected population. J Allergy Clin Immunol (1986) 0.96
MICA, MICB, and MHC beta block matching in bone marrow transplantation: relevance to transplantation outcome. Hum Immunol (2006) 0.95
Direct observation of the gene organization of the complement C4 and 21-hydroxylase loci by pulsed field gel electrophoresis. J Exp Med (1989) 0.95
The implications of intergenic polymorphism for major histocompatibility complex evolution. Genetics (2000) 0.95
Epidemiology of late presentation of HIV infection in Western Australia. Med J Aust (1992) 0.95
Coevolution of PERB11 (MIC) and HLA class I genes with HERV-16 and retroelements by extended genomic duplication. J Mol Evol (1999) 0.95
Corneodesmosin gene: no evidence for PSORS 1 gene in North-eastern Thai psoriasis patients. Tissue Antigens (2003) 0.94
HLA in systemic lupus erythematosus: influence on severity. Tissue Antigens (1978) 0.94
Cytotoxic effect of antisera on 51Cr-labelled monolayers of skeletal muscle. J Pathol (1973) 0.93
Angioimmunoblastic lymphadenopathy with dysproteinemia. Cancer (1977) 0.93
Cluster of TRIM genes in the human MHC class I region sharing the B30.2 domain. Tissue Antigens (2003) 0.93
The major histocompatability complex (MHC) contains conserved polymorphic genomic sequences that are shuffled by recombination to form ethnic-specific haplotypes. J Mol Evol (1997) 0.93
Letter: Penicillamine therapy, antistriational antibody, and myasthenia gravis. Br Med J (1975) 0.92
Myogenesis in vitro as demonstrated by immunofluorescent staining with antimuscle serum. Exp Cell Res (1971) 0.92
Major histocompatibility complex (MHC) complement deficiency, ancestral haplotypes and systemic lupus erythematosus (SLE): C4 deficiency explains some but not all of the influence of the MHC. J Rheumatol (1991) 0.92
Changes in human milk composition during the initiation of lactation. Aust J Exp Biol Med Sci (1981) 0.92
Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles. Immunogenetics (1985) 0.92
A global study of forensically significant calliphorids: implications for identification. Forensic Sci Int (2008) 0.91
Composition of breast fluid of a man with galactorrhea and hyperprolactinaemia. J Clin Endocrinol Metab (1981) 0.91
Vacuolar myopathy associated with chloroquine, lupus erythematosus and thymoma. Report of a case with unusual mitochondrial changes and lipid accumulation in muscle. J Neurol Sci (1977) 0.91
Immunoglobulin deposition in liver of patients with active chronic hepatitis and antibody against smooth muscle. Br Med J (1973) 0.90
C4 allotyping on plasma or serum: application to routine laboratories. Hum Immunol (1988) 0.90
Diversity of MICA (PERB11.1) and HLA haplotypes in Northeastern Thais. Tissue Antigens (2001) 0.90
Antinuclear antibody. Precise and accurate quantitation without serial dilution. J Immunol Methods (1986) 0.90
Immunological assessment of mice with chronic jaundice and runting induced by reovirus 3. Br J Exp Pathol (1973) 0.90
Haplotypic polymorphisms of the TNFB gene. Immunogenetics (1991) 0.90
Normal and caesarian section delivery and the initiation of lactation in women. Aust J Exp Biol Med Sci (1981) 0.89
Genomic organization of a polymorphic duplicated region centromeric of HLA-B. Immunogenetics (1992) 0.89
Comparison between two human endogenous retrovirus (HERV)-rich regions within the major histocompatibility complex. J Mol Evol (1999) 0.88
The evolution of MHC diversity by segmental duplication and transposition of retroelements. J Mol Evol (1997) 0.88
The reactivity of the antistriational antibodies associated with thymoma and myasthenia gravis. Clin Exp Immunol (1977) 0.88
Polymyositis and myasthenia gravis: immunodeficiency disorders involving skeletal muscle. Lancet (1975) 0.88
Allelic and interlocus comparison of the PERB11 multigene family in the MHC. Immunogenetics (1997) 0.88